PMID: 517476Dec 1, 1979Paper

Periodic transfusions for sickle cell anemia and CNS infarction

American Journal of Diseases of Children
S A SarnaikJ M Lusher

Abstract

Recurrences of CNS infarction often lead to progressive neurologic disability in sickle cell anemia. To prevent such reccurrence, a periodic blood transfusion program was begun in 1969. Currently, 27 patients are on this regimen. Before inclusion in the program, 12 patients had had one to nine CNS recurrences each. Since the program was started, two patients have had transient CNS ischemia. There were no other recurrences and none of the patients have shown progression of neurologic abnormalities. In addition, there was a striking decrease in bacterial infection and pain. We conclude that periodic transfusions are effective in preventing recurrent CNS infarction in sickle cell anemia. The benefits must be weighed against the potentially serious problem of iron overload, as evidenced by moderately elevated serum ferritin values.

Citations

Mar 11, 1998·Controlled Clinical Trials·R J AdamsM A Waclawiw
Sep 1, 1987·Postgraduate Medical Journal·P C HindmarshS C Davies
Jul 29, 2004·Current Treatment Options in Neurology·Fenella J. Kirkham, Michael R. DeBaun
Dec 14, 2011·Hematology·Jeffrey D LebensburgerAlexis A Thompson
Jul 8, 2008·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·S A NoreldeenS Pavord
Feb 14, 2016·Current Neurology and Neuroscience Reports·Courtney Lawrence, Jennifer Webb
Dec 14, 2005·Critical Care Nursing Clinics of North America·Kathryn E Roberts
Oct 24, 2006·Current Problems in Pediatric and Adolescent Health Care·Rupa Redding-Lallinger, Christine Knoll
Apr 7, 2009·British Journal of Haematology·Banu AygunUNKNOWN SWiTCH Trial Investigators
Jun 6, 2003·British Journal of Haematology·Janet L KwiatkowskiKwaku Ohene-Frempong
Jul 23, 2009·American Journal of Hematology·John J StrouseJames F Casella
Sep 8, 2011·American Journal of Hematology·Susanna Bortolusso AliMarvin Reid
Dec 31, 1997·The American Journal of Emergency Medicine·P C FerreraH Swanson
Nov 1, 1988·The Journal of Pediatrics·S T MillerA K Brown
Sep 1, 1986·The Journal of Pediatrics·T G Quattlebaum, M M Pierce
Apr 11, 2000·Neurologic Clinics·G F Lynch, P B Gorelick
May 1, 1983·The American Journal of Medicine·S CharacheD S Bross
May 3, 2000·British Journal of Haematology·D R Powars
Mar 17, 2007·Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence·Winfred C Wang
Mar 1, 1988·The Journal of Pediatrics·S A SarnaikS Bond
Dec 1, 1983·The Journal of Pediatrics·G R BuchananS J Smith
Nov 1, 1994·Stroke; a Journal of Cerebral Circulation·N VenketasubramanianS Piomelli
Mar 12, 2002·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·Constance F M Danielson
Jan 18, 2017·The Cochrane Database of Systematic Reviews·Lise J EstcourtWinfred C Wang
Nov 2, 2005·Pediatric Blood & Cancer·Alexis A Thompson
Jan 1, 1993·Journal of Clinical Apheresis·B C McLeodH G Klein
Jun 21, 2013·Expert Review of Hematology·Jennifer Webb, Janet L Kwiatkowski
Jul 28, 2020·The Cochrane Database of Systematic Reviews·Lise J EstcourtWinfred C Wang
Oct 6, 2016·Pediatric Research·Emily Riehm Meier, Angeli Rampersad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.